IRWD vs PATH · P/E 5.7, rev $90.5M vs P/E 19, rev $1.61B
Ironwood Pharmaceuticals Inc (IRWD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IRWD revenue for 2024-12-31 was $90.5M. Net income was $2.3M. Revenue was down 1.1% from 2024-09-30 to 2024-12-31. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IRWD and PATH stock pages for the full models.
Not investment advice.